Philip Cyr, MPH

A-D
Written By Guest User

SENIOR VICE PRESIDENT
Pharmaceutical Commercialization

My specialty is developing and communicating health economic and outcomes research evidence, pricing strategies, and interacting with medical affairs professionals and payers for over 30 years across a wide range of therapeutic areas. Specific expertise in advanced therapies having supported more than 30 cell and gene therapies including 10 that have been approved on the market.

Guest User
Previous

Nate Collins, DVM, PhD, DACVP
Next

Carson Dickey